Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma

CONCLUSION: In patients with unresectable LA BCC, the combination of vismodegib and RT yielded high rates of LRC and PFS and durable improvements in PRQOL.PMID:38630954 | DOI:10.1200/JCO.23.01708

Source: Cancer Control - April 17, 2024 Category: Cancer & Oncology Authors: Christopher A Barker Suzanne Dufault Sarah T Arron Alan L Ho Alain P Algazi Lara A Dunn Audrey A Humphries Carter Hultman Ming Lian P Daniel Knott Sue S Yom Source Type: research